PDL Biopharma, Inc., 10% Owner at LENSAR, Inc. (LNSR), bought 17,406 shares at $11.16 ($194K) on 2020-09-29, disclosed to the SEC on 2020-10-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.16 | 8,703 | $97K | 50.0% |
| 2 | $11.16 | 8,703 | $97K | 50.0% |
| Total | $11.16 avg | 17,406 | $194K | 100% |